Clinical Trial Update: A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating sunitinib for recurrent and/or metastatic adenoid cystic carcinoma of the salivary glands.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Salivary Gland Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Adenoid Cystic Carcinoma, Salivary Gland Cancer | Phase 2 | Status: COMPLETED